Vericel Corp (VCEL) 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated August 1, 2024, reports the financial results for Vericel Corporation for the fiscal quarter ended June 30, 2024. The filing serves to incorporate by reference a press release (Exhibit 99.1) detailing the company's second-quarter 2024 performance.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the attached press release (Exhibit 99.1) but are not explicitly stated in the body of this 8-K document.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative analysis.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information furnished in this report and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, except as expressly set forth by specific reference. No specific guidance, outlook, or risk factors are detailed in the text of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2024 revenue and net income figures.
- Verify year-over-year and quarter-over-quarter growth rates in the attached press release.
- Check the press release for updated full-year 2024 financial guidance.
- Confirm cash position and liquidity details in the referenced financial statements.